EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer

Yuki Kochi, Satoshi Hosoya, Nozomu Yanaihara, Chie Nagata, Rie Honda, Miwako Shimazaki, Kota Yokosu, Takafumi Kuroda, Motoaki Saito, Hiroshi Tanabe, Kyosuke Yamada, Hirokuni Takano und 1 weitere

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02559-3 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Yuki Kochi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato-Ku, Tokyo, 105-8461, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Carboplatin, Carcinoma, Ovarian Epithelial. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsBevacizumabCarboplatinCarcinoma, Ovarian EpithelialOvarian NeoplasmsPaclitaxelAdultAgedAged, 80 and overFemaleHumansMiddle AgedEast Asian PeopleJapanProgression-Free SurvivalRetrospective Studies

Stichwörter der Autor:innen

BevacizumabClinical trialDose-dense TCEpithelial ovarian cancerJapaneseSurvival outcomes

Substanzen

BevacizumabCarboplatinPaclitaxel

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato-Ku, Tokyo, 105-8461, Japan.
  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato-Ku, Tokyo, 105-8461, Japan. yanazou@jikei.ac.jp.

Zitieren

APA

Kochi, Y., Hosoya, S., Yanaihara, N., Nagata, C., Honda, R., Shimazaki, M., Yokosu, K., Kuroda, T., Saito, M., Tanabe, H., Yamada, K., Takano, H., & Okamoto, A. (2024). Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02559-3

Vancouver

Kochi Y, Hosoya S, Yanaihara N, Nagata C, Honda R, Shimazaki M, et al. Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02559-3

BibTeX
@article{Kochi2024,
  author = {Kochi, Yuki and Hosoya, Satoshi and Yanaihara, Nozomu and Nagata, Chie and Honda, Rie and Shimazaki, Miwako and Yokosu, Kota and Kuroda, Takafumi and Saito, Motoaki and Tanabe, Hiroshi and Yamada, Kyosuke and Takano, Hirokuni and Okamoto, Aikou},
  title = {Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02559-3}
}
Kostenlos starten →